Form 8-K - Current report:
SEC Accession No. 0001558370-25-008415
Filing Date
2025-06-05
Accepted
2025-06-05 08:30:13
Documents
14
Period of Report
2025-06-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hrmy-20250605x8k.htm   iXBRL 8-K 45722
2 EX-99.1 hrmy-20250605xex99d1.htm EX-99.1 31545
3 GRAPHIC hrmy-20250605xex99d1001.jpg GRAPHIC 10901
  Complete submission text file 0001558370-25-008415.txt   213842

Data Files

Seq Description Document Type Size
4 EX-101.SCH hrmy-20250605.xsd EX-101.SCH 3296
5 EX-101.LAB hrmy-20250605_lab.xml EX-101.LAB 15926
6 EX-101.PRE hrmy-20250605_pre.xml EX-101.PRE 10079
16 EXTRACTED XBRL INSTANCE DOCUMENT hrmy-20250605x8k_htm.xml XML 4831
Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Filer) CIK: 0001802665 (see all company filings)

EIN.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39450 | Film No.: 251025089
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)